Japan Agency for Medical Research and Development
Overview
A Japanese government funding agency established in 2015 to promote integrated medical research and development, from basic research to practical applications. It aims to accelerate the translation of research into healthcare solutions by consolidating R&D budgets from multiple ministries and providing streamlined support for projects in areas like regenerative medicine, rare diseases, infectious diseases, and oncology.
Portfolio Companies
30
Website
amed.go.jpInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| B dot Medical Inc. | Jul 2020 | Grant | Co-investor |
| PRD Therapeutics | Jun 2024 | Grant | Co-investor |
| CellFiber, Inc. | Nov 2022 | Grant | Co-investor |
| United Immunity, Co., Ltd. | Feb 2026 | Grant | Co-investor |
| J-Pharma | Apr 2025 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Japan Agency for Medical Research and Development based?
Japan Agency for Medical Research and Development is headquartered in Tokyo.
When was Japan Agency for Medical Research and Development founded?
Founding year information for Japan Agency for Medical Research and Development is not publicly available.
How many portfolio companies does Japan Agency for Medical Research and Development have?
Japan Agency for Medical Research and Development has 30 portfolio companies in Caplight's dataset.
What are some companies in Japan Agency for Medical Research and Development's portfolio?
Portfolio companies visible on Caplight include B dot Medical Inc., PRD Therapeutics, CellFiber, Inc., United Immunity, Co., Ltd., J-Pharma.
What was Japan Agency for Medical Research and Development's most recent investment shown here?
Japan Agency for Medical Research and Development's most recent investment in this portfolio sample was in United Immunity, Co., Ltd. in 2026.
What sectors does Japan Agency for Medical Research and Development focus on?
Japan Agency for Medical Research and Development focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Japan Agency for Medical Research and Development focus on?
Japan Agency for Medical Research and Development typically invests at the MultiStage stage.